India Promotes Organ Donation Movement
The Ministry of Health and Family Welfare has issued letters urging governors of all states and union territories to create awareness among students of all universities. Citizens can pledge organ donation online on NOTTO website or by scanning the QR code available through NOTTO website.
Updates On Use of Olaparib Tablets for Ovarian Cancer Treatment
The initially approved use of Olaparib for advanced ovarian cancer in patients with a gBRCA mutation and who have received three or more prior chemotherapy treatments is being withdrawn.
Protect Yourself from Hepatitis Outbreak in Wayanad
In response to reported cases of hepatitis across various locales in Wayanad, the District Medical Officer underscores the importance of staying vigilant against this viral disease.
New Guidelines for Head of Department Appointments in Central Government Hospitals
These guidelines aim to create a more transparent and standardized selection process for HoDs. The emphasis on eligibility and qualifications aims to ensure qualified leadership for these departments.
NPPA Revises Ceiling Price Of Budesonide (A) +Formoterol (B)
Now, by the present corrigendum NPPA has revised the ceiling price for Budesonide (A) +Formoterol (B). The ceiling price has now been fixed as Rs. 6.95/ per dose. This applies to the dosage in the form of Inhalation (DPI) 400mcg(A) +6 mcg (B).
NPPA Fixes Ceiling Price of New Drugs and Scheduled Formulations
The National Pharmaceutical Pricing Authority (NPPA) has set maximum prices for certain new drug formulations made by specific companies. Additionally, NPPA has also fixed ceiling prices for certain scheduled formulations. The ceiling prices specified are exclusive of GST and apply to the respective dosage forms, strengths, and units detailed in the entries.
Regulation Against Excessive And Irrational Use Of Antibiotics
State Licensing Authorities (SLAs) are required to submit a list of all licensed antibiotic combinations within two weeks. They shall also monitor their jurisdiction for the presence of unapproved antibiotic combinations and take action against violators. SLAs shall also report any unapproved combinations to the CDSCO on a priority basis.
CDSCO Publishes List Of Drugs Declared As Not Of Standard Quality And Spurious For April 2024
The spurious drug list specifies a total of 5 products/ drugs that were detected to be spurious in nature. The NSQ drug list specifies a total of 50 products/ drugs that were detected to be not of standard quality. Out of these 33 were reported from CDSCO/Central Laboratories and the remaining 17 were reported from state laboratories.
CDSCO Warns Staff Against Improper Use of Digital Signatures
Digital Signature Certificates enable secure electronic signatures for online processes like form submissions, No Objection Certificates (NOCs), and document transmission. CDSCO emphasizes that employees must use their DSCs personally in their official capacities.
Grace Period Granted for Class C & D Medical Device Licensing
CDSCO has decided that existing importers and manufacturers of Class C & D medical devices who submitted license applications to the Central Licensing Authority (CLA) by September 30, 2023, can continue their operations till August 16, 2024.
